Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Ildong Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	58,433	72,267	53,258	52,146	135,586	85,564
Short-Term Investments	10,110	12,605	28,021	16,600	19,095	600
Trading Asset Securities	-	-	-	10,000	-	-
Cash & Short-Term Investments	68,543	84,872	81,279	78,746	154,681	86,164
Cash Growth	-3.34%	4.42%	3.22%	-49.09%	79.52%	-4.85%
Accounts Receivable	45,525	44,613	56,245	53,916	51,818	49,517
Other Receivables	9,638	10,073	2,735	4,158	3,026	1,241
Receivables	70,376	66,977	62,650	58,074	54,844	50,758
Inventory	98,195	87,939	84,623	98,249	82,587	89,227
Prepaid Expenses	2,190	2,150	1,623	1,270	1,363	1,408
Other Current Assets	4,314	5,053	5,506	45,697	7,008	5,686
Total Current Assets	243,619	246,991	235,681	282,035	300,485	233,243
Property, Plant & Equipment	218,522	221,443	256,380	255,317	247,790	256,419
Long-Term Investments	25,360	23,729	18,996	21,395	22,432	21,675
Goodwill	5,527	5,527	5,527	5,527	5,527	-
Other Intangible Assets	21,097	22,681	30,079	31,401	38,926	38,283
Long-Term Accounts Receivable	-	277.35	442.14	542.83	-	-
Long-Term Deferred Tax Assets	55,529	55,670	53,888	43,822	66,016	24,935
Long-Term Deferred Charges	5,429	6,151	6,505	10,193	22,174	24,788
Other Long-Term Assets	7,185	4,590	1,689	3,630	3,808	4,213
Total Assets	583,776	589,043	611,261	655,810	708,970	605,277
Accounts Payable	43,744	47,616	50,250	46,099	38,334	35,988
Accrued Expenses	27,819	30,985	33,277	33,734	34,930	20,804
Short-Term Debt	128,485	122,647	176,497	140,743	88,400	65,400
Current Portion of Long-Term Debt	53,597	3,443	13,000	1,000	42,000	23,000
Current Portion of Leases	4,866	4,606	3,575	6,618	4,035	3,956
Current Income Taxes Payable	568.1	1,475	68.3	268.05	7.55	129.16
Current Unearned Revenue	-	-	-	-	600	-
Other Current Liabilities	49,522	57,969	64,728	82,182	149,456	35,733
Total Current Liabilities	308,601	268,739	341,395	310,644	357,763	185,010
Long-Term Debt	-	56,208	3,000	16,000	60,404	42,000
Long-Term Leases	21,146	18,644	16,654	43,387	31,316	32,500
Long-Term Deferred Tax Liabilities	321.14	393.05	1.43	6.06	-	-
Other Long-Term Liabilities	16,342	12,623	8,644	9,688	10,375	10,328
Total Liabilities	416,335	422,758	431,880	451,940	542,008	350,730
Common Stock	28,063	28,063	28,063	26,803	23,803	23,803
Additional Paid-In Capital	53,327	173,327	173,359	377,287	210,262	209,614
Retained Earnings	67,080	-50,942	-58,540	-211,102	-81,951	14,856
Treasury Stock	-2,308	-2,307	-2,307	-365.05	-365.05	-365.05
Comprehensive Income & Other	17,049	12,618	28,968	-1,379	1,159	6,640
Total Common Equity	163,211	160,758	169,543	191,244	152,909	254,547
Minority Interest	-2,997	-1,701	4,723	6,981	7,676	-
Shareholders' Equity	167,441	166,285	179,381	203,870	166,962	254,547
Total Liabilities & Equity	583,776	589,043	611,261	655,810	708,970	605,277
Total Debt	208,095	205,548	212,726	207,748	226,155	166,856
Net Cash (Debt)	-139,551	-120,675	-131,447	-129,002	-71,474	-80,692
Net Cash Per Share	-4996.05	-4320.27	-4862.98	-4896.88	-3004.97	-3392.40
Filing Date Shares Outstanding	27.93	27.93	27.93	26.79	23.79	23.79
Total Common Shares Outstanding	27.93	27.93	27.93	26.79	23.79	23.79
Working Capital	-64,982	-21,748	-105,713	-28,609	-57,279	48,233
Book Value Per Share	5843.09	5755.27	6069.76	7139.87	6428.69	10701.87
Tangible Book Value	136,587	132,550	133,936	154,315	108,456	216,264
Tangible Book Value Per Share	4889.92	4745.41	4795.03	5761.20	4559.77	9092.34
Land	50,816	50,816	72,561	35,125	35,125	35,125
Buildings	89,352	140,049	141,614	140,941	140,732	138,731
Machinery	53,777	202,503	211,982	206,257	195,601	185,845
Construction In Progress	2,172	1,393	3,694	1,963	3,683	5,988

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.